Table 2 Distribution of ELBW (n = 117) according to neonatal complications
From: Prospective study of early and late outcomes of extremely low birthweight in Central Saudi Arabia
Complications | Total (n = 117) n, (%) |
|---|---|
A-CNS | |
IVH | 75 (64.1) |
PVL | 10 (8.5) |
Encephalopathy | 6 (5.1) |
Seizure | 25 (21.4) |
Retinopathy of prematurity (ROP) | |
Grade I | 45 (38.8) |
Grade II | 6 (5.2) |
B-CVS | |
PDA | 66 (56.9) |
CHD | 4 (3.4) |
Indomethacin | 20 (17.2) |
Pulmonary Hypertension | 13 (11.4) |
C-Infectious | |
Early Onset Sepsis | 11 (9.5) |
Late Onset Sepsis | 47 (40.5) |
Nosocomial Infection | 41 (35.7) |
Meningitis | 4 (3.4) |
D-Respiratory | |
RDS | 110 (95.7) |
Surfactant | 101 (87.8) |
Air Leak Syndrom | 1 (0.9) |
BPD-Bronchopulmonary dysplasia | 42 (36.5) |
Postnatal Steroid | 27 (23.5) |
Phototherapy | 86 (75.4) |
IPPVduration of oxygen exposure (days) | 26.6 ± 22.5 |
CPAPduration of mechanical ventilation (days) | 16.9 ± 15.5 |
Home oxygen | 3 (3.5) |
E-GIT | |
GIT abnormalities | 2 (1.8) |
Necrotizing enterocolitis (NEC) –stage II | 31 (27.0) |
Hyperbilirubinemia | 82 (71.9) |
Phototherapy | 86 (75.4) |